-
Research Groups
-
Lewin Group
The focus of the Lewin group is to understand why HIV infection persists on antiretroviral therapy and to develop new strategies to eliminate latency. The lab also researches factors that drive liver disease in HIV-hepatitis B virus co-infection. The lab is also actively involved in COVID in relation to pathogenesis, the use of primary tissue models, and developing therapeutics using gene editing strategies.
Other work areas include:Immunology, Viral Infectious Diseases
Current Projects
Lab Team
-
Director - The Peter Doherty Institute for Infection and Immunity
-
Senior Research Fellow
-
Senior Research Fellow
-
Dr Wei ZhaoResearch Fellow
-
Dr Chris ChiuResearch Fellow
-
Dr Youry KimResearch Fellow
-
Dr Stan KanResearch Fellow
-
Dr Jill LauClinical Research Fellow
-
Clinical Research Liason Officer
-
Dr Judy ChangResearch Systems Administrator
-
Dr Catherine KennedyResearch Coordinator
-
Research Coordinator
-
Laboratory Manager
-
Infectious Diseases Physician
-
Carolin TumpachResearch Support Officer
-
Rosalyn CaoResearch Support Officer
-
Danielle FongResearch Support Officer
-
Abigail TanResearch Support Officer
-
Jared SternPhD Candidate
-
Rachel PascoePhD Candidate
-
Paula CevaalPhD Candidate
-
Haoming LiuPhD Candidate
-
Kiho TanakaPhD Candidate
-
Rory ShepherdPhD Candidate
-
Lauren WallaceHonours Student
-
Bridget FisherHonours Student
-
Associate Professor Edwina WrightClinical Affiliate
-
Dr James McMahonClinical Affiliate
-
Head, Clinical Virology and HIV Services, Deputy Director Department of Infectious Diseases Austin Health
-
Associate Professor Thomas RasmussenClinical Affiliate
-
Bowden Group
Scott’s laboratory is the State Reference Laboratory for molecular testing of the hepatitis viruses and has been involved in outbreak investigation of hepatitis A, B, C and E for the Victorian Department of Health, as well as for other Australian states.
-
Cowie Group
Ben’s group focuses on viral hepatitis epidemiological research. The team undertakes a broad range of activities supporting local, national and global control of viral hepatitis, through surveillance, treatment and prevention initiatives, and training and regional capacity building.
Other work areas include:Public Health
-
Locarnini Group
The current major research interests of Stephen’s group includes viral hepatitis and antiviral chemotherapy with an emphasis on the basic virology of hepatitis B virus, the molecular pathogenesis of hepatitis, as well as prevention and public health control measures.
-
Nicholson Group
Suellen's group fulfills a dual mission of providing a technically first class, reliable diagnostic, reference and public health service to the healthcare system, and being an innovative, adaptable, forward-looking component of the scientific community and a valued collaborator in research projects, not just in Victoria, but nationally and in the region.
Other work areas include:HIV
-
Revill Group
The Revill Group is focusing on developing novel mechanisms to cure chronic hepatitis B disease, targeting multiple aspects of the virus replication cycle and stimulating antiviral host immune responses
-
Walsh Group
Renae’s group studies key HBV proteins to predict clinical response during chronic disease towards understanding the interaction with/recognition by the host antibody response to clear infection, and how the antibody response might be enhanced to promote viral clearance and cure.
Now recruiting volunteers
There are currently no Now recruiting volunteers
Current projects
-
Hepatitis HIV
A surveillance program for the detection of hepatitis B virus (HBV) resistance to tenofovir (TDF) in HIV-HBV co-infected patient
-
Hepatitis
Characterising Hepatitis B in northern Australia through Molecular epidemiology - longitudinal cohort study
-
Hepatitis
Liver Cancer Prevention: linking viral hepatitis diagnosis, treatment and outcomes
-
Hepatitis HIV
Long-term persistence of HIV in the liver and the clinical impact on HIV-HBV co-infection (CHHANEL)
-
Hepatitis HIV
Towards a Functional cure for HBV: exploiting lessons from HBV-HIV co-infection
-
Over
400 million
people are chronically infected with hepatitis B or C globally
450,000
Australians
are living with chronic viral hepatitis